Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Trop2-targeted immunoPET Imaging of Solid Tumors [Phase 2, Phase 3]
Clinical trial update for Trop2-targeted immunoPET imaging of solid tumors, currently in Phase 2/3 and recruiting.
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Study Assessing PET Imaging With Zirconium-labelled Girentuximab in Patients With HCC, ICC or NEN [NA]
A clinical trial is evaluating PET imaging with zirconium-labelled girentuximab in patients with hepatocellular carcinoma, intrahepatic chol…
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Durvalumab With/Without Tremelimumab After Palliative Hypofractionated Radiotherapy for Hepatocellular Carcinoma [Phase 2]
Phase 2 clinical trial evaluating durvalumab with or without tremelimumab after palliative hypofractionated radiotherapy for hepatocellular …
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: T-Cell Therapy (ECT204) in Adults With Advanced HCC [Phase 1, Phase 2]
A Phase 1/2 trial of the T-cell therapy ECT204 for adults with advanced hepatocellular carcinoma is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-12-05Clinical Trial Update: BOXR1030 T Cells in Subjects With Advanced GPC3-Positive Solid Tumors [Phase 1, Phase 2]
Clinical trial update for BOXR1030 T Cells shows a Phase 1/2 study in GPC3-positive solid tumors, including hepatocellular carcinoma and add…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer [Phase 1]
Phase 1 trial evaluating the combination of guadecitabine and durvalumab in advanced cholangiocarcinoma, gallbladder cancer, hepatocellular …
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program [Phase 2]
Phase 2 trial evaluating in-home versus in-clinic subcutaneous nivolumab administration under the CC Beyond Walls program; the study is curr…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Role of Omega-6 Fatty Acids in Hepatocellular Carcinoma Development.
A clinical trial registry entry from Sohag University investigating the role of omega-6 fatty acids in the development of hepatocellular car…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Cabozantinib to Treat Recurrent Liver Cancer Post Transplant [Phase 2]
This clinical trial update notes a Phase 2 study of cabozantinib for recurrent hepatocellular carcinoma in liver transplant patients, and it…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid Tumors [Phase 1]
Phase 1 study of TBI-1301, an NY-ESO-1–specific TCR gene-transduced autologous T cell therapy, in solid tumors; the trial is currently activ…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Study of GV20-0251 in Participants With Solid Tumor Malignancies [Phase 1, Phase 2]
GV20 Therapeutics is evaluating GV20-0251 in a Phase 1/2 trial for adults with various solid tumors, and the study is currently recruiting. …
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: A Phase I Clinical Study of Recombinant Humanized Anti-BTLA Monoclonal Antibody (JS004) Injection Combined With Toripalimab Injection in Patients With Advanced Solid Tumors [Phase 1]
A Phase I trial of JS004, a recombinant humanized anti-BTLA monoclonal antibody, in combination with toripalimab for advanced solid tumors h…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Infusional FOLFOX Plus Camrelizumab and Apatinib vs HAIC-FOLFOX Plus Camrelizumab and Apatinib for Advanced HCC [Phase 3]
A Phase 3 trial update comparing infusional FOLFOX plus Camrelizumab and Apatinib versus HAIC-FOLFOX plus Camrelizumab and Apatinib for adva…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: HRYZ-T102 TCR-T Cell for AFP Positive Advanced HCC and Other Solid Tumors [Phase 1]
Phase 1 clinical trial update for HRYZ-T102 TCR-T cell therapy targeting AFP-positive advanced hepatocellular carcinoma and other solid tumo…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Adjuvant PD-1 Inhibitor for Patients With Early-stage Hepatocellular Carcinoma Following Microwave Ablation [NA]
This clinical trial update notes recruitment for an adjuvant PD-1 inhibitor in patients with early-stage hepatocellular carcinoma after micr…
-
CLINICAL_TRIALS research · 2025-12-01Clinical Trial Update: Precision Medicine for Liver Tumours With Quantitative Magnetic Resonance Imaging and Whole Genome Sequencing
Clinical trial evaluating precision medicine for liver tumours using quantitative MRI and whole-genome sequencing, sponsored by Perspectum; …
-
CLINICAL_TRIALS research · 2025-12-01Clinical Trial Update: ICIs and Anti-VEGF Antibody/TKIs With or Without Interventional Therapy for Advanced HCC [Phase 2]
This is a Phase 2 clinical trial evaluating immune checkpoint inhibitors with or without anti-VEGF antibody or tyrosine kinase inhibitors fo…
-
CLINICAL_TRIALS trial_result · 2025-12-01Clinical Trial Update: Cabozantinib toLERANCE Study in HepatoCellular Carcinoma (CLERANCE) [Phase 4]
A Phase 4 clinical trial (CLERANCE) evaluating cabozantinib in hepatocellular carcinoma has completed. The document provides no trial result…
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: TAF Monotherapy Versus ETV Combined With TAF on the Efficacy and Prognosis of Immunotherapy for Hepatitis B-Related Hepatocellular Carcinoma [NA]
This clinical trial protocol compares tenofovir alafenamide (TAF) monotherapy to entecavir (ETV) plus TAF for hepatitis B-related hepatocell…
-
CLINICAL_TRIALS trial_result · 2025-11-28Clinical Trial Update: Study of ACC-1898 in Adult Participants With Advanced Solid Tumors [Phase 1]
Phase 1 study update for ACC-1898 in adults with advanced solid tumors; the trial is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer
This clinical trial update describes a noninvasive miRNA-based test being explored for screening gastrointestinal cancers. It is currently r…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: National Liver Cancer Screening Trial [Phase 4]
Phase 4 liver cancer screening trial is currently recruiting, sponsored by the University of Texas Southwestern Medical Center.
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: A Single-arm Phase II Clinical Study Investigating the Safety and Efficacy of Carbon Ion Radiotherapy in Patients With Hepatocellular Carcinoma Previously Treated With Transarterial Radioembolization (TARE) [NA]
A single-arm Phase II clinical trial evaluating carbon ion radiotherapy for hepatocellular carcinoma in patients previously treated with tra…
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Neo-Adjuvant TACE and Atezolizumab Plus Bevacizumab Therapy for High-Risk Recurrent Hepatocellular Carcinamo [Phase 2]
This Phase 2 trial is evaluating the safety and effectiveness of neoadjuvant TACE combined with atezolizumab and bevacizumab in patients wit…
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: Clinical Trial of TB511 in Advanced Solid Tumors [Phase 1, Phase 2]
This update covers an early-phase trial of TB511 in advanced solid tumors, including non-small cell lung cancer and prostate cancer, with co…